Home › Funds › OAKTREE CAPITAL MANAGEMENT LP › ENOV

OAKTREE CAPITAL MANAGEMENT LP position in ENOV

ENOVIS CORPORATION · Health Care

OAKTREE CAPITAL MANAGEMENT LP reported holding 39,207,000 shares of ENOV (ENOVIS CORPORATION) in its Q2 2026 13F filing — a position valued at US$37.8M, representing 0.55% of its reported portfolio and ranking #45 among its reported holdings. OAKTREE CAPITAL MANAGEMENT LP first reported this position in Q2 2026.

Latest position (Q2 2026)39.21M sh
Reported value held$37.79M
Portfolio Weight0.55%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How OAKTREE CAPITAL MANAGEMENT LP's ENOV position evolved

OAKTREE CAPITAL MANAGEMENT LP first disclosed a stake in ENOV in Q2 2026 at 39,207,000 shares (US$37.8M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 39.21M $37.79M New

About ENOV and 13F data

ENOV (ENOVIS CORPORATION) is a Health Care company. 18 other funds we track also report a position in ENOV — the largest reported positions include Rubric Capital Management LP (US$80.7M), PARADIGM CAPITAL MANAGEMENT INC/NY (US$28.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENOV

All ENOV fund holders →

FAQ

How long has OAKTREE CAPITAL MANAGEMENT LP held ENOV?

OAKTREE CAPITAL MANAGEMENT LP has disclosed ENOV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is OAKTREE CAPITAL MANAGEMENT LP's current position in ENOV?

As of Q2 2026, OAKTREE CAPITAL MANAGEMENT LP holds 39.21M shares of ENOV (ENOVIS CORPORATION), valued at $37.79M, representing 0.55% of its reported portfolio and ranking #45.

Has OAKTREE CAPITAL MANAGEMENT LP been buying or selling ENOV?

In the latest 13F filing (Q2 2026), OAKTREE CAPITAL MANAGEMENT LP newly opened its position in ENOV.

Which other funds hold ENOV?

Other major institutional holders of ENOV include Rubric Capital Management LP, PARADIGM CAPITAL MANAGEMENT INC/NY, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.